Afuco™ Anti-IL17A ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H57) (CAT#: AFC-TAB-H57)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Humanized (from mouse) antibody to Human IL17A. It is a humanized monoclonal antibody designed for the treatment of arthritis. It binds to IL17A and acts as an immunomodulator.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Specificity
  • IL17A (interleukin 17A, IL-17A) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut
  • Conjugate
  • Unconjugated
  • Generic Name
  • Perakizumab
  • Related Disease
  • Rheumatoid arthritis (RA)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IL-17; 3C1; IL17A; interleukin 17A; CTLA8, IL17, interleukin 17 (cytotoxic T lymphocyte associated serine esterase 8); interleukin-17A; cytotoxic T lymphocyte associated protein 8; IL 17; IL 17A; CTLA-8;

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Perakizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Perakizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "perakizumab"

Anti-Human IL17A Recombinant Antibody (Perakizumab)
Recombinant Humanized (from mouse) antibody to Human IL17A. Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis. It binds to IL17A and acts as an immunomodulator.

See other products for "IL17A"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Products Rat Antibody Products Mouse Antibody Products Human Antibody Products Fc Glycosylation Antibody Products Chicken IgY Antibody Products Neutralizing Antibody Products ScFv Antibody Products IgG Antibody Products Neuroscience Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads Flow Cytometry (FC) related Products ScFv-Fc Chimera Products
CAT Product Name Application Type
TAB-H57 Anti-Human IL17A Recombinant Antibody (Perakizumab) WB, ELISA, IP, FC, FuncS, Neut, IF IgG1 - kappa
TAB-H08 Anti-Human IL17A/IL17F Recombinant Antibody (TAB-H08) ELISA, FC, IP, FuncS, IF, Neut, WB IgG1 - kappa
TAB-048ZJ Human Anti-IL17A Recombinant Antibody (TAB-048ZJ) ELISA, Neut Humanized antibody
TAB-048ZJ-S(P) Human Anti-IL17A Recombinant Antibody; scFv Fragment (TAB-048ZJ-S(P)) ELISA, Neut Human scFv
TAB-458CQ Anti-Human IL17A Recombinant Antibody (TAB-458CQ) ELISA, IHC, FC, IP, IF, Inhib IgG1, κ

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H57. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare